from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2465c/rpiB

LFCtreatmentdescriptionclass of inhibitor

1.187

Amikacinug/mL Amikacintranslation

2.255

Cap5-10ug/mL Capreomycintranslation

2.731

Rox10-50 ug/mL Roxithromycintranslation

0.579

SM2-5 ug/mL Streptomycintranslation

2.531

Tet5-10 ug/mL Tetracyclinetranslation

-0.273

Rif0.2-5ug/mL Rifampicintranscription

-0.018

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.826

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.355

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.573

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.500

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.401

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.124

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.222

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.049

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.638

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.248

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.641

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.713

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

2.610

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.282

KCN5-20 ug/mL Potassium cyaniderespiration

-0.085

NaN30.2-2 mM Sodium aziderespiration

-0.081

Nigericin50 uM Nigericinrespiration

-0.389

TRC10-150 ug/mL Triclosanrespiration

-0.615

TRZ10-25 ug/mL Thioridazinerespiration

0.032

Valinomycin0.5-10 uM Valinomycinrespiration

-0.155

ZnSO42 mM ZnSO4respiration

3.944

menadione6-10 ug/mL Menadionerespiration

-0.409

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.001

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.088

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.217

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.127

NRP_1Non-replicating persistence stage 1dosRassociated

-0.061

Amp0.2mg/mL AmpicillincellWall

-0.178

Cephalexin20-100 ug/mL CephalexincellWall

-0.073

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.328

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.291

EMB10-20 ug/mL EthambutolcellWall

-0.208

Eta12-40 ug/mL EthionamidecellWall

-0.157

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.304

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.704

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.389

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.165

BZA0.12 mg/mL BenzamidearomaticAmides

-0.069

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.164

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.424

H2O24 mM hydrogen peroxideDNAdamaging

-0.205

Levo10 ug/mL LevofloxacinDNAdamaging

-0.076

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.783

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.250

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.157

UVUV-irradiationDNAdamaging

4.227

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.290

Antimycin12.5-50 ug/mL Antimycin A?

-0.348

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.158

PA_110-50 ug/mL Antitubercular compound PA-1?

0.051

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.795

PA8240.2-2 ug/mL PA-824?

-0.528

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.400

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.387

Verapamil50 uM Verapamil?

0.037

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.391

methoxatin10-20 ug/mL Methoxatin?